Investigation of the effect of olanzapine in patients undergoing chemotherapy

Phase 3

Recruiting

• Conditions: cancer.; Secondary malignant neoplasm of unspecified site; C79.9

• Registration Number: IRCT20240505061661N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 27 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 180

Inclusion Criteria

pregnancy

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Weight. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: scale.;Nausea. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Interview and clinical examination.;Anorexia. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Functional evaluation questionnaire for treatment of chronic anorexia nervosa.

Secondary Outcome Measures

Name	Time	Method
C-Reactive Protein (CRP). Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Laboratory kit (blood test).;Albumin. Timepoint: Before the intervention and 12 weeks after the intervention. Method of measurement: Laboratory kit (blood test).